ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,148 | -18.2% | 15,830 | -7.4% | 0.00% | 0.0% |
| Q2 2023 | $347,300 | -32.5% | 17,100 | -39.4% | 0.00% | 0.0% |
| Q1 2023 | $514,457 | +478.5% | 28,205 | +555.9% | 0.00% | – |
| Q4 2022 | $88,924 | -69.0% | 4,300 | -59.2% | 0.00% | – |
| Q2 2021 | $287,000 | -8.6% | 10,540 | -5.9% | 0.00% | -100.0% |
| Q1 2021 | $314,000 | +57.0% | 11,198 | +38.2% | 0.00% | – |
| Q2 2020 | $200,000 | -3.4% | 8,100 | -60.7% | 0.00% | – |
| Q4 2019 | $207,000 | +6.2% | 20,600 | -3.4% | 0.00% | – |
| Q3 2019 | $195,000 | +52.3% | 21,315 | +32.9% | 0.00% | – |
| Q2 2019 | $128,000 | – | 16,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |